Faculty

Institution

Unit

Venue

Homer Macapinlac

The University of Texas MD Anderson Cancer Center

Affiliations

Center For Nuclear Receptors And Cell Signaling

NoneHomer Macapinlac is currently serving as a Center For Nuclear Receptors And Cell Signaling faculty at The University of Texas Md Anderson Cancer Center.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Homer Macapinlac

The University of Texas MD Anderson Cancer Center

You can click a keyword to filter the displayed items

oncology radiation oncology cancer imaging radiology cancer research nuclear medicine oncologic imaging positron emission tomography immunology medicine cancer treatment tumor biology cancer care lymphoid neoplasia medical imaging oncogenes medicinal research thoracic oncology cell transplantation molecular imaging metastasis hematology cancer cells clinical research surgical oncology cellular therapy cancer biology gastrointestinal oncology clinical transplantation molecular cancer biomedical imaging pet-mri cell therapy tumor targeting transplantation medicine radiation therapy prostatic disease radiopharmaceutical therapy clinical radiation oncology bone marrow transplantation clinical investigation pharmacotherapy tumoral pathology cancer management genitourinary cancers hematological malignancies anti-cancer agents cancer detection tumor heterogeneity cancer genomics breast imaging cancer growth stem cell transplantation gastrointestinal stromal tumors imatinib resistance relapsed follicular lymphoma ibritumomab tiuxetan skeletal tumor burden treatment and prevention cancer education reconstructive surgery disease progression cancer genetics esophageal cancer cohort studies quantitative analysis imatinib mesylate treatment fdg pet findings missense mutation pathologic response neoadjuvant chemotherapy prognostic factors overall survival clinical utility tumor types task force

Notable Scholarly Works

Notable Federal Grants

Collaborators

Assessing the Effectiveness of Selective Ret Inhibitors in Ret-Positive Cancers Through Fluorodeoxyglucose Uptake Analysis. Diagnostics (2024)

oncogenesradiation oncologyanti-cancer agentsret-positive cancerscancer imagingcancer researchcancer discoverycancer growthpharmacologytherapeutic targetscancer cellsselective ret inhibitorscancer treatmentfluorodeoxyglucose uptake analysisoncology

Deciphering Tumor Response: The Role of Fluoro-18-D-Glucose Uptake in Evaluating Targeted Therapies With Tyrosine Kinase Inhibitors. Journal of Clinical Medicine (2024)

tumor biologytumor responsedrug targetinganti-cancer agentscell biologybrain tumor researchmolecular cancertyrosine kinase inhibitorsevaluating targeted therapiespharmacologytherapeutic targetscancer cellscancer treatmentoncology

Safety, Efficacy and Determinants of Response of Allogeneic Cd19-Specific Car-Nk Cells in Cd19+ B Cell Tumors: A Phase 1/2 Trial. Nature Medicine (2024)

David MarinYe LiRafet BasarHind RafeiMay DaherJinzhuang DouVakul MohantyMerve DedeYago NietoNadima UpretySunil AcharyaEnli LiuJeffrey WilsonPinaki BanerjeeHomer A. MacapinlacChristina GaneshPeter F. ThallRoland BassettMariam AmmariSheetal RaoKai CaoMayra ShanleyMecit KaplanChitra HosingPartow KebriaeiLoretta J. NastoupilChristopher R. FlowersSadie Mae MoseleyPaul LinSonny AngUday R. PopatMuzaffar H. QazilbashRichard E. ChamplinKen ChenElizabeth J. ShpallKatayoun Rezvani

cancer caretumor targetingtumor biologycell therapyanti-cancer agentscancer immunotherapyimmunologymedicinal researchcell transplantationcellular therapycancer researchpharmacologymedicinecancer cellscancer treatmentclinical trialsoncologycancer biology

Sodium Fluoride (Na18F) Pet Response Criteria in Solid Tumors (Nafcist): A Framework for Response Assessment in Bone Tumors. ESMO Open (2023)

pathologyradiation oncologypositron emission tomographybone imagingresponse assessmentsodium fluorideradiologycancer imagingcancer researchnuclear medicineoncologic imagingpet response criteriaoncologybone research

Positron Emission Tomography Derived Metrics in Relapsed or Refractory Large B‐Cell Lymphoma With Residual Disease Before Autologous Stem Cell Transplant. British Journal of Haematology (2022)

Hua‐Jay J. CherngGuofan XuLei FengRaphael SteinerLuis FayadPaolo StratiRanjit NairLoretta J. NastoupilHun Ju LeeSattva S. NeelapuChristopher R. FlowersMaria RodriguezMichael WangFredrick HagemeisterChelsea C. PinnixJeremy RamdialSamer SrourYago NietoKatayoun RezvaniRichard ChamplinPartow KebriaeiJason WestinHomer A. MacapinlacElizabeth ShpallSairah Ahmed

residual diseasepositron emission tomographyimmunologymedical imaginghepatologyhematologydermatologycell transplantationhematological malignanciescancer researchstem cell transplantationlymphoid neoplasiahealth sciencesoncologytransplantation medicine

18F-Fluorothymidine Pet is an Early and Superior Predictor of Progression-Free Survival Following Chemoimmunotherapy of Diffuse Large B Cell Lymphoma: A Multicenter Study. European Journal of Nuclear Medicine and Molecular Imaging (2021)

Ryogo MinamimotoLuis FayadJulie VoseJane MezaRanjana AdvaniJordan HankinsFelix MottaghyHomer MacapinlacAlexander HeinzelMalik E. JuweidAndrew Quon

multicenter studyradiation oncologymulti-scale studieslymphoid neoplasiaimmunologyprogression-free survivalmolecular imagingnuclear sciencecancer researchnuclear medicinenuclear magnetic resonance spectroscopymedicinecancer treatmentnuclear magnetic resonanceoncology

18F-Sodium Fluoride Positron Emission Tomography (Naf-18-Pet/Ct) Radiomic Signatures to Evaluate Responses to Alpha-Particle Radium-223 Dichloride Therapy in Osteosarcoma Metastases. Current Problems in Cancer (2021)

Kalevi KairemoJason RoszikPete AndersonGregory RavizziniArvind RaoHomer A. MacapinlacVivek Subbiah

radiomicsthoracic oncologybone researchtumor biologyradiologycancer researchcancer treatmentradiation oncologypositron emission tomographymedical imagingradiomic signaturescancer carecancer biologymetastasistumor targetingcancer imagingosteosarcoma metastasesmedicineleukemiaoncology

Monoclonal Antibody Based Radiopharmaceuticals for Imaging and Therapy. Current Problems in Cancer (2021)

radiation oncologybiological imagingtheranosticsmedical imagingimmunotherapymolecular imagingradiologycancer imagingmonoclonal antibodynuclear medicinetherapeutic imagingradiopharmaceutical therapytherapeutic targetsbiomedical imaging

New Pet Radiopharmaceuticals for Cancer Imaging. Nuclear Medicine and Molecular Imaging (2021)

positron emission tomographymedical imagingfunctional imagingradiologycancer imagingoncologic imagingnuclear medicineradiopharmaceutical therapybiomedical imaging

Early Response Assessment to Targeted Therapy Using 3′-Deoxy-3′[(18)F]-Fluorothymidine (18F-Flt) Pet/Ct in Lung Cancer. Diagnostics (2020)

radiation oncologyearly response assessmentpositron emission tomographymedical imagingmolecular imaginglung cancerradiologycancer imagingoncologic imagingnuclear medicinetherapeutic targetsthoracic oncologyoncology

1
2
3
4
5
10 / page

Homer Macapinlac

The University of Texas MD Anderson Cancer Center

Affiliations

Center For Nuclear Receptors And Cell Signaling

NoneHomer Macapinlac is currently serving as a Center For Nuclear Receptors And Cell Signaling faculty at The University of Texas Md Anderson Cancer Center.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Homer Macapinlac

The University of Texas MD Anderson Cancer Center

You can click a keyword to filter the displayed items

Notable Scholarly Works

Notable Federal Grants

Collaborators

Assessing the Effectiveness of Selective Ret Inhibitors in Ret-Positive Cancers Through Fluorodeoxyglucose Uptake Analysis. Diagnostics (2024)

Deciphering Tumor Response: The Role of Fluoro-18-D-Glucose Uptake in Evaluating Targeted Therapies With Tyrosine Kinase Inhibitors. Journal of Clinical Medicine (2024)

Safety, Efficacy and Determinants of Response of Allogeneic Cd19-Specific Car-Nk Cells in Cd19+ B Cell Tumors: A Phase 1/2 Trial. Nature Medicine (2024)

Sodium Fluoride (Na18F) Pet Response Criteria in Solid Tumors (Nafcist): A Framework for Response Assessment in Bone Tumors. ESMO Open (2023)

Positron Emission Tomography Derived Metrics in Relapsed or Refractory Large B‐Cell Lymphoma With Residual Disease Before Autologous Stem Cell Transplant. British Journal of Haematology (2022)

Ryogo MinamimotoLuis FayadJulie VoseJane MezaRanjana AdvaniJordan HankinsFelix MottaghyHomer MacapinlacAlexander HeinzelMalik E. JuweidAndrew Quon

Kalevi KairemoJason RoszikPete AndersonGregory RavizziniArvind RaoHomer A. MacapinlacVivek Subbiah

Monoclonal Antibody Based Radiopharmaceuticals for Imaging and Therapy. Current Problems in Cancer (2021)

New Pet Radiopharmaceuticals for Cancer Imaging. Nuclear Medicine and Molecular Imaging (2021)

positron emission tomographymedical imagingfunctional imagingradiologycancer imagingoncologic imagingnuclear medicineradiopharmaceutical therapybiomedical imaging

Early Response Assessment to Targeted Therapy Using 3′-Deoxy-3′[(18)F]-Fluorothymidine (18F-Flt) Pet/Ct in Lung Cancer. Diagnostics (2020)

1
2
3
4
5
10 / page